throbber
Heat Sterilization of Thermally Labile Solutions*J
`By T. HIGUCHI and L. W. BUSSE
`
`A general criterion for choosing high or low temperature for sterilizing heat-
`sensitive pharmaceutical preparations is presented. A mathematical analysis of
`the competing processes involved shows that the choice of temperature is largely
`dependent on the relative magnitudes of the heats of activation of the sterilization
`and the drug deterioration reactions. Results indicate, for example, that for pro-
`caine solutions, autoclaving at 120' is preferable to prolonged sterilization at 100'.
`
`R = the universal gas constant
`T = the absolute temperature of sterilization
`K = a constant depending on the number and
`kind of the most thermally resistant
`species present
`The above expression is a modified form of the
`classical Arrhenius equation.
`In Fig. 1 a typical relationship between In ta
`and temperature is shown. Also shown in the
`figure is the type of relationship found between the
`half life (the time required for 50y0 decomposition)
`of a thermally labile drug, such as procaine, and
`absolute temperature. This can be expressed
`similarly mathematically by the equation
`
`In t i / % = AH:/RT + C
`
`(2)
`
`where
`t i / , = the half life of the drug at temperature
`T
`AH,* = the heat of activation of the decomposi-
`tion reaction
`C = a constant
`
`RE LATlONSHl P OF STERILIZATION
`TIME AND HALF LIFE TO TEMPERA
`
`Lo 9
`time
`t
`
`HE PROBLEM of the relative merits of steriliz-
`ing heat-sensitive solutions a t one or another
`temperature is often encountered by those en-
`gaged in pharmaceutical
`investigations. The
`question, for example, whether a procaine solu-
`tion should be sterilized by autoclaving or
`sterilized a t 100" has often been debated. In
`the present study, a general criterion for deciding
`whether higher or lower sterilization temperature
`is to be preferred in preparation of a thermally
`sensitive solution is presented. Although the
`actual application is made to the case of procaine
`solutions, the method is generally applicable to
`nearly all thermally labile solutions.
`
`THEORETICAL CONSIDERATION
`
`The sterilization process involves, essentially, ir-
`reversible denaturation of certain vital enzyme-
`proteins in the microorganisms present. Since in-
`activation of enzymes and denaturation of proteins
`appear to be of
`the unimolecular type, we can
`reasonably expect the death rate of microorganisms
`to follow the first order reaction law (1). In case of
`ordinary sterilization, however, the picture is com-
`plicated by the fact that several varieties of micro-
`organisms are present. Furthermore, thermal sens -
`tivity of a given type of an organism may be ap-
`preciably different at different stages of its life cycle.
`Nevertheless it has been found experimentally that
`the first order law is followed reasonably well during
`the terminal part of the sterilization process. This
`can be rationalized in view of the fact that only
`the most thermophilic of the original flora is present
`during the terminal course of the process.
`On the basis of the above discussion and experi-
`inental evidence, we can write the following equation
`relating the death time, t d . necessary for total
`sterilization to the absolute temperature of steriliza-
`tion,
`
`In td = AH:/RT
`
`K
`
`(1)
`
`I / T
`Figure 1
`
`where
`td = the necessary sterilization time
`AH: = the heat of activation characteristic of
`It is evident from the curve that a t a low tem-
`killing most thermally resistant species
`perature ( A ) the half life of the drug may be much
`present
`shorter than the necessary sterilization time; yet
`at a higher temperature (B) sterilization of the drug
`* Received May 16, 1950, from the Research Laboratories
`may be achieved in a small fraction of its half life.
`of the School of Pharmacy, University of Wisconsin, Madi-
`The determining factor for such a situation is that
`son. t This project was supported in part by the Research
`the sterilization line has a much sharper slope than
`Committee of the Graduate School from funds supplied by
`the line representing the decomposition reaction.
`the Wisconsin Alumni Research Foundatcon.
`41 1
`
`MYLAN ET AL. - EXHIBIT 1019
`
`

`
`41 2
`ASSOCIATION
`JOURNAL OF THE AMERICAN PHARMACEUTICAL
`to be 14 kilocalories. Since for all practical
`Since the relative slopes of
`these lines depend
`the compound is
`directly on the magnitude of their respective AH*
`pharmaceutical preparations
`values, the above condition would be fulfilled if
`found in its salt form, only the former value need
`AH: > AH:.
`If we subtract Eq. 2 from Eq. 1
`be considered. These workers also found that the
`we obtain
`hydrolysis reaction of ionic procaine was iirst order
`In id - In t l l z = [AH? - AHf] F~ + K - C
`with respect to hydroxyl ions.
`It appears from arguments put forth in the pre-
`ceding section that since 12 kilocalories is much
`less than 50 kilocalories, sterilization of procaine
`1 - j. + Constant
`AH: -
`solutions is more advantageously carried out at
`t d
`In- =
`higher than at lower temperatures.
`In solutions
`R
`t . / 2
`buffered with acid type buffers, e.g., phosphate,
`AH: - A H a I +Constant
`log - =
`h
`borate, etc., the advantage of high temperature
`2.303 X 1.987 T
`ti/*
`sterilization is, however, considerably less. This is
`due to the fact that although these buffers maintain
`and if we let R = t d / t ‘ / z then at temperatures T A
`fairly constant pH values over wide temperature
`and TB we have
`ranges, hydroxyl ion concentration changes very
`rapidly with temperature. The increased hydrolysis
`rates resulting from higher hydroxyl concentration
`a t higher temperatures correspond to added heat of
`activation of 10-13 kilocalories (the heat of ioniza-
`
`) t>e exact value de-
`
`tion of water = 2.30R-
`d(1lT)
`pending on temperature.. In unbuffered or solutions
`buffered with an amine type buffer, the hydroxyl
`ion concentration is roughly independent of tem-
`perature and the correction may be omitted. In
`either case the apparent heat of activation of the
`hydrclysis reacticn is still well below the previously
`mentioned 50 kilocalories value for the sterilization
`reaction. The calculated Rjoo/Rim for unbuffered
`procaine solutions is roughly 12. Far solutions
`buffered with acid type buffers RioolRruo, calculated
`with Eq. 3, is approximately 8. For reasons
`stated above, sterilization by autoclaving for a short
`time is thus preferable to relatively long steriliza-
`tion a t 100” for procaine solutions.
`
`REFERENCES
`
`(1) Porter, J. R. “Bacterial Chemistry trod Physiology,”
`John Wiley and S o k , N e w York, 1946, pp. 172-192.
`(2) Higuchi, T.. Havinga. A. L., and Busse, L. W., THIS
`JOURNAL, 39,405(1950).
`
`or
`
`1
`
`The ratio RA/RB may be thought of as an improve-
`ment factor which expresses numerically the rela-
`tive rate advantage of sterilization over decom-
`position in going from T A to TLL If RA/RB is
`greater than unity higher temperature is to be pre-
`ferred. The value of RA/RB can be solved for any
`particular situation if numerical values of AH:
`and AH,* are known.
`AH: values obtained
`thermophilic
`for most
`microorganisms and spores appear to be over 50
`kilocalories. Those forms which have AH.* less
`than 50 kilocalories are relatively heat sensitive
`and do not influence the sterilization time. AH,*
`must be obtained for each drug.
`Application to Procaine Solutions
`Recently Higuchi, Havinga, and Busse (2) com-
`pleted a chemical kinetic study of the rate of hydrol-
`ysis of procaine in solution. The data obtained
`indicate that the rate of hydrolysis of the ionic
`form of the drug was entirely different from that of
`the free base form. The calculated heat of activa-
`tion for the hydrolysis of
`the salt form was 12
`kilocalories. That for the free base form was shown
`
`WHO MAKES IT?
`
`The National Registry of Rare Chemicals, Armour Research Foundation, 33rd, Ferleral and
`Dearborn Streets, Chicago, Ill., seeks information on sources of supply for the following chemicals:
`
`Trypiticase
`S-Benzylhomocysteine
`Chavicine
`Carene
`Neomenthol
`1.3-Diphosphoglyceric acid
`5,6-Dimethylbenzimidazole
`2- (d-Pantoylamino)ethylsulfono-4-chloroanilide
`m-Hydroxypropadrine
`bis-Dihydrocitronellyl ether
`
`Dodecyltriethylammonium bromide
`p-Fluoropropionic acid
`Soya lipase
`Carnegine
`Estriol glucuronate
`Barbatinic acid
`Hemipic acid
`Erythropleine
`Xanthotoxin
`Laurone

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket